01.11.2020 • NewsBASF

BASF to Close Herbicide Plants

BASF has announced it will close two herbicide plants by 2022 as it seeks to strengthen its competitive position. The facilities are located in Knapsack, Germany, where the company currently operates three plants, and Muskegon, Michigan, USA. The closures will affect about 100 workers.

The sites produce non-selective herbicide glufosinate-ammonium (GA) and its intermediates. BASF said that in future, production will be concentrated at plants and sites in Germany, Canada and the US.

“This step is part of further developing the GA business long-term to strengthen BASF’s competitive positioning in the non-selective herbicide segment to better serve our customers,” said Vincent Gros, president of BASF’s Agricultural Solutions division. “We remain committed to the GA product line, as the recently announced acquisition of the Glu-L technology from AgriMetis shows.”

BASF bought Glu-L in September, a move it said will enable it to provide farmers with an improved formulation to protect against troublesome weeds. Farmers applying Glu-L technology can reduce the amount of crop protection they need to apply by up to 50%, BASF said.

Glu-L has been submitted to the US Environmental Protection Agency and will launch in the next few years upon approval.

Author: Elaine Burridge, Freelance Journalist

BASF will close two herbicide plants in Knapsack, Germany, and Muskegon,...
BASF will close two herbicide plants in Knapsack, Germany, and Muskegon, Michigan, USA, by 2022, as it seeks to strengthen its competitive position. The sites produce non-selective herbicide glufosinate-ammonium and its intermediates. The closures will affect about 100 workers. Picture: Bosch

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.